CH578017A5 - - Google Patents

Info

Publication number
CH578017A5
CH578017A5 CH138669A CH138669A CH578017A5 CH 578017 A5 CH578017 A5 CH 578017A5 CH 138669 A CH138669 A CH 138669A CH 138669 A CH138669 A CH 138669A CH 578017 A5 CH578017 A5 CH 578017A5
Authority
CH
Switzerland
Application number
CH138669A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH578017A5 publication Critical patent/CH578017A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH138669A 1968-01-29 1969-01-29 CH578017A5 (US20110009641A1-20110113-C00185.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4570/68A GB1260465A (en) 1968-01-29 1968-01-29 11beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
CH578017A5 true CH578017A5 (US20110009641A1-20110113-C00185.png) 1976-07-30

Family

ID=9779640

Family Applications (2)

Application Number Title Priority Date Filing Date
CH45972A CH592688A5 (US20110009641A1-20110113-C00185.png) 1968-01-29 1969-01-29
CH138669A CH578017A5 (US20110009641A1-20110113-C00185.png) 1968-01-29 1969-01-29

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH45972A CH592688A5 (US20110009641A1-20110113-C00185.png) 1968-01-29 1969-01-29

Country Status (14)

Country Link
JP (2) JPS4828907B1 (US20110009641A1-20110113-C00185.png)
AT (1) AT309703B (US20110009641A1-20110113-C00185.png)
BE (1) BE727578A (US20110009641A1-20110113-C00185.png)
BR (1) BR6905985D0 (US20110009641A1-20110113-C00185.png)
CH (2) CH592688A5 (US20110009641A1-20110113-C00185.png)
DE (1) DE1904325C3 (US20110009641A1-20110113-C00185.png)
DK (1) DK128715B (US20110009641A1-20110113-C00185.png)
ES (1) ES363068A1 (US20110009641A1-20110113-C00185.png)
FR (1) FR2000924A1 (US20110009641A1-20110113-C00185.png)
GB (1) GB1260465A (US20110009641A1-20110113-C00185.png)
IE (1) IE33924B1 (US20110009641A1-20110113-C00185.png)
IL (1) IL31515A0 (US20110009641A1-20110113-C00185.png)
NL (1) NL6901342A (US20110009641A1-20110113-C00185.png)
SE (2) SE364267B (US20110009641A1-20110113-C00185.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52119945U (US20110009641A1-20110113-C00185.png) * 1976-03-08 1977-09-12
US5710293A (en) * 1995-10-13 1998-01-20 The Population Council, Center For Biomedical Research Method of preparation of ester derivatives of steroids

Also Published As

Publication number Publication date
JPS4828907B1 (US20110009641A1-20110113-C00185.png) 1973-09-05
ES363068A1 (es) 1971-06-16
FR2000924A1 (US20110009641A1-20110113-C00185.png) 1969-09-19
IL31515A0 (en) 1969-03-27
AT309703B (de) 1973-08-27
DK128715B (da) 1974-06-24
GB1260465A (en) 1972-01-19
IE33924B1 (en) 1974-12-11
DE1904325B2 (de) 1978-02-16
NL6901342A (US20110009641A1-20110113-C00185.png) 1969-07-31
IE33924L (en) 1969-07-29
BR6905985D0 (pt) 1973-04-19
SE386903B (sv) 1976-08-23
BE727578A (US20110009641A1-20110113-C00185.png) 1969-07-29
CH592688A5 (US20110009641A1-20110113-C00185.png) 1977-11-15
JPS4830051B1 (US20110009641A1-20110113-C00185.png) 1973-09-17
DE1904325A1 (de) 1969-09-04
DE1904325C3 (de) 1978-10-26
SE364267B (US20110009641A1-20110113-C00185.png) 1974-02-18

Similar Documents

Publication Publication Date Title
AU428130B2 (US20110009641A1-20110113-C00185.png)
AU416157B2 (US20110009641A1-20110113-C00185.png)
JPS4830051B1 (US20110009641A1-20110113-C00185.png)
AU2581067A (US20110009641A1-20110113-C00185.png)
AU2952567A (US20110009641A1-20110113-C00185.png)
AU421558B1 (US20110009641A1-20110113-C00185.png)
AU3789668A (US20110009641A1-20110113-C00185.png)
AU2580267A (US20110009641A1-20110113-C00185.png)
AU3224368A (US20110009641A1-20110113-C00185.png)
BE727220A (US20110009641A1-20110113-C00185.png)
BE727917A (US20110009641A1-20110113-C00185.png)
BE728296A (US20110009641A1-20110113-C00185.png)
AU4224469A (US20110009641A1-20110113-C00185.png)
AU4270368A (US20110009641A1-20110113-C00185.png)
BE727488A (US20110009641A1-20110113-C00185.png)
BE708951A (US20110009641A1-20110113-C00185.png)
AU3083868A (US20110009641A1-20110113-C00185.png)
BE727381A (US20110009641A1-20110113-C00185.png)
BE709095A (US20110009641A1-20110113-C00185.png)
BE727039A (US20110009641A1-20110113-C00185.png)
BE726303A (US20110009641A1-20110113-C00185.png)
BE725718A (US20110009641A1-20110113-C00185.png)
BE725497A (US20110009641A1-20110113-C00185.png)
BE724345A (US20110009641A1-20110113-C00185.png)
BE728072A (US20110009641A1-20110113-C00185.png)

Legal Events

Date Code Title Description
PL Patent ceased